Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nick Dand

Showing results (11-20 of 69) with videos related to

Pageof 7
Sort By:
The Journal of Investigative Dermatology|January 2, 2025
GWAS Meta-Analysis Identifies Susceptibility Loci for Keloids and Hypertrophic Scarring in EuropeansNick Dand, Chuin Y Ung, Jake R Saklatvala, et al.
The British Journal of Dermatology|December 5, 2023
The association of age at psoriasis onset and HLA-C*06:02 with biologic survival in patients with moderate-to-severe psoriasis: a cohort study from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR)Oras A Alabas, Kayleigh J Mason, Zenas Z N Yiu, et al.
The Journal of Investigative Dermatology|May 27, 2025
Investigating the Genetic Basis of the Influence of Adiposity on Psoriasis: A Cross-Sectional Study in a Large United Kingdom Population-Based BiobankRavi Ramessur, Jake Saklatvala, Mari Løset, et al.
The Journal of Allergy and Clinical Immunology|September 10, 2023
Genome-wide meta-analysis implicates variation affecting mast cell biology in urticariaSheila Mary McSweeney, Jake Saklatvala, Rossella Rispoli, et al.
The Journal of Investigative Dermatology|March 4, 2023
Genetic Validation of Psoriasis Phenotyping in UK Biobank Supports the Utility of Self-Reported Data and Composite Definitions for Large Genetic and Epidemiological StudiesJake R Saklatvala, Ken B Hanscombe, Satveer K Mahil, et al.
Clinical and Experimental Dermatology|May 16, 2024
Disagreement concerning atopic dermatitis subtypes between an English prospective cohort (ALSPAC) and linked electronic health recordsJulian Matthewman, Amy Mulick, Nick Dand, et al.
The British Journal of Dermatology|November 12, 2023
Characteristics of 'super responders' and 'super nonresponders' to first biologic monotherapy for psoriasis: a nested case-control studyKayleigh J Mason, Oras A Alabas, Nick Dand, et al.
JAMA Cardiology|September 18, 2024
Exploring the Link Between Genetic Predictors of Cardiovascular Disease and PsoriasisRavi Ramessur, Jake Saklatvala, Ashley Budu-Aggrey, et al.
Science Translational Medicine|October 13, 2017
An analysis of IL-36 signature genes and individuals with <i>IL1RL2</i> knockout mutations validates IL-36 as a psoriasis therapeutic targetSatveer K Mahil, Marika Catapano, Paola Di Meglio, et al.
The Journal of Investigative Dermatology|February 22, 2023
Atopic Polygenic Risk Score Is Associated with Paradoxical Eczema Developing in Patients with Psoriasis Treated with BiologicsAli Al-Janabi, Steve Eyre, Amy C Foulkes, et al.
Pageof 7

Showing results (11-20 of 69) with videos related to

Sort By:
Pageof 7
The Journal of Investigative Dermatology|January 2, 2025
GWAS Meta-Analysis Identifies Susceptibility Loci for Keloids and Hypertrophic Scarring in EuropeansNick Dand, Chuin Y Ung, Jake R Saklatvala, et al.
The British Journal of Dermatology|December 5, 2023
The association of age at psoriasis onset and HLA-C*06:02 with biologic survival in patients with moderate-to-severe psoriasis: a cohort study from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR)Oras A Alabas, Kayleigh J Mason, Zenas Z N Yiu, et al.
The Journal of Investigative Dermatology|May 27, 2025
Investigating the Genetic Basis of the Influence of Adiposity on Psoriasis: A Cross-Sectional Study in a Large United Kingdom Population-Based BiobankRavi Ramessur, Jake Saklatvala, Mari Løset, et al.
The Journal of Allergy and Clinical Immunology|September 10, 2023
Genome-wide meta-analysis implicates variation affecting mast cell biology in urticariaSheila Mary McSweeney, Jake Saklatvala, Rossella Rispoli, et al.
The Journal of Investigative Dermatology|March 4, 2023
Genetic Validation of Psoriasis Phenotyping in UK Biobank Supports the Utility of Self-Reported Data and Composite Definitions for Large Genetic and Epidemiological StudiesJake R Saklatvala, Ken B Hanscombe, Satveer K Mahil, et al.
Clinical and Experimental Dermatology|May 16, 2024
Disagreement concerning atopic dermatitis subtypes between an English prospective cohort (ALSPAC) and linked electronic health recordsJulian Matthewman, Amy Mulick, Nick Dand, et al.
The British Journal of Dermatology|November 12, 2023
Characteristics of 'super responders' and 'super nonresponders' to first biologic monotherapy for psoriasis: a nested case-control studyKayleigh J Mason, Oras A Alabas, Nick Dand, et al.
JAMA Cardiology|September 18, 2024
Exploring the Link Between Genetic Predictors of Cardiovascular Disease and PsoriasisRavi Ramessur, Jake Saklatvala, Ashley Budu-Aggrey, et al.
Science Translational Medicine|October 13, 2017
An analysis of IL-36 signature genes and individuals with <i>IL1RL2</i> knockout mutations validates IL-36 as a psoriasis therapeutic targetSatveer K Mahil, Marika Catapano, Paola Di Meglio, et al.
The Journal of Investigative Dermatology|February 22, 2023
Atopic Polygenic Risk Score Is Associated with Paradoxical Eczema Developing in Patients with Psoriasis Treated with BiologicsAli Al-Janabi, Steve Eyre, Amy C Foulkes, et al.
Pageof 7